Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
Wang Wang(Inserm), Gavin Y. Oudit(Inserm)
Cited by 211
Related Papers
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
|Diabetes|2009|304
Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17
|Hypertension|2016|196
Pharmacological and cell-specific genetic PI3Kα inhibition worsens cardiac remodeling after myocardial infarction
|Journal of Molecular and Cellular Cardiology|2021|14